Crossref
The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease
Journal of Exploratory Research in Pharmacology · 2017
DOI: 10.14218/jerp.2016.00016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Exploratory Research in Pharmacology, 2017. Verfasst von Devika Kapuria und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kapuria, D., & Chhabra, R. (2017). The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease. Journal of Exploratory Research in Pharmacology. https://doi.org/10.14218/jerp.2016.00016
Vancouver
Kapuria D, Chhabra R. The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease. Journal of Exploratory Research in Pharmacology. 2017. doi:10.14218/jerp.2016.00016
BibTeX
@article{Kapuria2017,
author = {Kapuria, Devika and Chhabra, Rajiv},
title = {The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease},
journal = {Journal of Exploratory Research in Pharmacology},
year = {2017},
doi = {10.14218/jerp.2016.00016}
}
EUVIMED